BJERKHOLT ERIC

CFO Eric Bjerkholt sells 7,287 shares of MIRM at $91.98; stock now $96.55. His 4 prior MIRM trades all well-timed at 90d.

Eric Bjerkholt, Chief Financial Officer, sold 7,287 shares at $91.98 on 2026-03-16 for $670,242.96, reducing his holdings by 12.8% to 49,788 shares. The sale occurred 30 days before the current price of $96.55, meaning the stock has risen 4.9% since the transaction. Examining his history at MIRM specifically, all 4 of his prior trades at this ticker have been well-timed at the 90-day mark, including a previous sell on 2025-09-12 that preceded a 13.5% decline over 90 days. His cross-ticker track record shows 1 prior sell with a 100.00% well-timed rate at the 90-day horizon. The stock trades 11.1% below its 52-week high of $108.62, having declined 6.4% over the prior 30 days despite a +39.9% gain over 90 days. The company carries a high P/E of 254.08 with negative full-year net income despite 54.7% annual revenue growth. The sale pattern—reducing a concentrated position in a high-multiple, unprofitable company—aligns with the insider's demonstrated ability to execute well-timed transactions in this security, though the immediate 30-day price action cuts against that narrative so far.

CFO Eric Bjerkholt sold 9,578 shares of Mirum (MIRM) at $76.01, reducing stake by 19.3% to 39,945 shares.

Eric Bjerkholt, CFO of Mirum Pharmaceuticals, sold 9,578 shares at $76.01 on 2025-09-12, generating $728,023.78 and reducing his holdings by 19.3% from 49,523 to 39,945 shares. The sale occurred near the 52-week high of $77.69, just 4.4% below peak valuation. Notably, Bjerkholt's prior three purchases at MIRM were well-timed at the 90-day mark, with average 90-day returns of +14.97% across those buys; the timing pattern at this ticker has consistently favored his entry points. The current sale at elevated valuations, combined with the company's unprofitable status (net income of $-5.9M in the latest quarter despite 80.8% annual revenue growth), suggests a shift in the insider's position management around the stock near its recent peak.